[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367778-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367778-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","oncogenic-mechanisms-of-kaposis-sarcoma-associated-herpesvirus-on-cell-metabolism-and-cell-transformation","Oncogenic Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus on Cell Metabolism and Cell Transformation","","Kaposi’s sarcoma-associated herpesvirus (KSHV) is a human double-stranded DNA virus responsible for Kaposi’s sarcoma, primary effusion lymphoma, multicentric Castleman’s disease, and KSHV inflammatory cytokine syndrome. KSHV infection alters cellular proteins and signaling pathways, enabling immune evasion, apoptosis inhibition, sustained proliferation, and cancer development. Existing treatments for KSHV-associated cancers remain limited and often face resistance. This review synthesizes recent findings on how KSHV drives metabolic reprogramming, cell immortalization, proliferation, and phenotypic transitions to support tumorigenesis and inform targeted therapeutics.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/oncogenic-mechanisms-of-kaposis-sarcoma-associated-herpesvirus-on-cell-metabolism-and-cell-transformation/367778/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/oncogenic-mechanisms-of-kaposis-sarcoma-associated-herpesvirus-on-cell-metabolism-and-cell-transformation/367778.png","ImageObject",300,407,{"name":42,"@type":43},"Mimi","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What cancers are associated with KSHV infection?","Question",{"text":63,"@type":64},"KSHV is associated with Kaposi’s sarcoma, primary effusion lymphoma, multicentric Castleman’s disease, and KSHV inflammatory cytokine syndrome.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does KSHV contribute to cancer development at the cellular level?",{"text":68,"@type":64},"KSHV manipulates cellular proteins and signaling pathways, promoting immune escape, inhibiting cell death, sustaining growth, and driving transformation.",{"name":70,"@type":61,"acceptedAnswer":71},"Why are current treatments for KSHV-associated cancers limited?",{"text":72,"@type":64},"The review notes that available therapies rely largely on conventional strategies and antiretroviral regimens with surgery, radiation, and chemotherapy, which are poorly or partially effective and can be accompanied by significant side effects.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367778,1790799048,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336477974920,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Journal of  \nMedical Virology  \nREVIEW   \nOncogenic Mechanisms of Kaposi's Sarcoma‐Associated Herpesvirus on Cell Metabolism and Cell Transformation  \nQuanyuan Wan  | Andrew J. Tucker | Jun Zhao   \nFlorida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, Florida, USA  \nCorrespondence: Quanyuan Wan ([wanq@ccf.org](wanq@ccf.org)) | Jun Zhao ([zhaoj6@ccf.org](zhaoj6@ccf.org))  \nReceived: 2 June 2025 | Revised: 24 July 2025 | Accepted: 8 August 2025  \nFunding: This work is supported by grants from the National Institute of Health (R00DE028973 and R01DE033632 to J.Z.) and startup funds from the Cleveland Clinic Florida Research and Innovation Center.  \nKeywords: cell cycle | human herpesvirus 8 (Kaposi sarcoma‐associated herpesvirus) | metabolic networks | oncogenesis | transformation | viral oncogenes  \nABSTRACT  \nKaposi's sarcoma‐associated herpesvirus (KSHV) is a human double‐stranded DNA virus that is responsible for the development of Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), multicentric Castleman's disease (MCD), and KSHV inflammatory cytokine syndrome (KICS) . KSHV infection manipulates distinct cellular proteins and signaling pathways, resulting in immune escape, cell death inhibition, infinite cell growth, and cancer formation. Current treatments for KSHV‐ associated cancers are limited to conventional strategies targeting nonviral cancers which encounter limited efficacy and drug resistance. Understanding the molecular and cellular mechanisms underlying KSHV tumorigenesis is essential for the development of effective prevention and targeted therapeutics. In this review, we summarize recent studies and provide an updated understanding of the mechanisms employed by KSHV for metabolic reprogramming, cell immortalization, cell proliferation, and cell transition.  \n1 | Introduction  \nThe association between virus and cancer was first discovered in the early 20th century when Peyton Rous demonstrated that Rous sarcoma virus causes tumors in chickens [1] . Shortly thereafter in 1964, Anthony Epstein, Bert Achong, and Yvonne Barr published evidence of the first human oncovirus, Epstein– Barr virus [2] . In 1994, Kaposi's sarcoma‐associated herpesvirus (KSHV, also named human herpesvirus 8, HHV‐8) was identified by Yuan Chang and Patrick Moore in AIDS‐associated Kaposi's sarcoma (KS) [3] . As one of the gamma herpesviruses, KSHV contains a large double‐stranded DNA genome (> 140 kb) encoding multiple open reading frames (ORFs) and noncoding RNAs [4, 5] . Following extensive investigations, KSHV is now defined as the causal agent of KS, multicentric Castleman's disease (MCD), primary effusion lymphoma (PEL), and more recently KSHV inflammatory cytokine syndrome  \n(KICS) [6, 7] . As such, KSHV persistent infection and viral pathogenesis in immunocompromised patients have become a public health concern. Three decades of molecular virology research suggest that the mechanisms by which KSHV induces cancer are complex and multifaceted, involving various viral and host factors as well as intricate interactions among the virus and the host cell machinery.  \nWhile the transmission routes of KSHV are not fully clarified, saliva is believed to be one of the primary routes for KSHV spreading [7] . As such, KSHV lytic replication in the oral epithelium contributes to virus shedding. Subsequently, KSHV establishes viral latency in different cell types including endothelial cells, fibroblasts, monocytes, B cells, etc., with its genome tethering to host DNA as a nonintegrating episome. During latency, limited viral products are expressed, that is, latent viral proteins and microRNAs, rendering KSHV's escape  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.  \n© 2025 The Author(s) . Jou","cbCaie7RaV2mW1VI","https://ap.wps.com/l/cbCaie7RaV2mW1VI","pdf",1141625,13,"English","# Introduction\n## Virus–cancer association and discovery of KSHV\n## KSHV transmission, latency, and lytic reactivation\n## Clinical relevance and therapeutic limitations\n# Overview of oncogenic mechanisms (metabolism, proliferation, transformation)","[{\"question\":\"What cancers are associated with KSHV infection?\",\"answer\":\"KSHV is associated with Kaposi’s sarcoma, primary effusion lymphoma, multicentric Castleman’s disease, and KSHV inflammatory cytokine syndrome.\"},{\"question\":\"How does KSHV contribute to cancer development at the cellular level?\",\"answer\":\"KSHV manipulates cellular proteins and signaling pathways, promoting immune escape, inhibiting cell death, sustaining growth, and driving transformation.\"},{\"question\":\"Why are current treatments for KSHV-associated cancers limited?\",\"answer\":\"The review notes that available therapies rely largely on conventional strategies and antiretroviral regimens with surgery, radiation, and chemotherapy, which are poorly or partially effective and can be accompanied by significant side effects.\"}]","Oncogenic Mechanisms of Kaposi's Sarcoma-Associated Herpesvirus on Cell Metabolism and Cell Transformation | PDF",1790172568,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33b72d21f8ed220d7842212f97e03a21.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0585ef1ba434136e6c029cba312d4720.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4e496b96b3c33e59581d02837ba56263.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c579a4efafe20981bd2114408d4c46a5.webp",980,1287]